Search

Your search keyword '"Baz, Rachid"' showing total 321 results
Start Over Author "Baz, Rachid" Database Unpaywall
321 results on '"Baz, Rachid"'

1. Effect of talquetamab on responses in patients with relapsed and refractory multiple myeloma with prior exposure to T-cell directed therapies.

Author

Graeter, Allison, primary, Castaneda Puglianini, Omar Alexis, additional, Hansen, Doris K., additional, Vazquez-Martinez, Mariola A., additional, Blue, Brandon Jamaal, additional, Khadka, Sushmita, additional, Liu, Hien, additional, Ochoa-Bayona, Jose L., additional, Freeman, Ciara L., additional, Locke, Frederick L, additional, Nishihori, Taiga, additional, Shain, Kenneth H., additional, Baz, Rachid C., additional, Alsina, Melissa, additional, and Grajales-Cruz, Ariel Felipe, additional

Published
2024
Full Text
View/download PDF

2. Metabolomic signatures of carfilzomib‐related cardiotoxicity in patients with multiple myeloma

Author

Shabnaz, Samia, primary, Nguyen, Trang N., additional, Williams, Roy, additional, Rubinstein, Samuel M., additional, Garrett, Timothy J., additional, Tantawy, Marwa, additional, Fradley, Michael G., additional, Alomar, Mohammed E., additional, Shain, Kenneth H., additional, Baz, Rachid C., additional, Lenihan, Daniel, additional, Cornell, Robert F., additional, Lu, Qing, additional, and Gong, Yan, additional

Published
2024
Full Text
View/download PDF

3. Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (SRs) in Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 Subanalysis of Black Patients (pts)

Author

Patel, Krina K., primary, Rodríguez-Otero, Paula, additional, Nooka, Ajay K., additional, Callander, Natalie S., additional, Solomon, Scott R., additional, Baz, Rachid, additional, Sborov, Douglas W., additional, Gergis, Usama, additional, Badros, Ashraf Z., additional, Giralt, Sergio A., additional, Pearse, Roger, additional, Abonour, Rafat, additional, Siegel, David S., additional, Larson, Sarah M., additional, Munshi, Nikhil C., additional, Truppel-Hartmann, Anna, additional, Bhatnagar, Rashmi, additional, Wu, Fan, additional, Piasecki, Julia, additional, Felten, Jasper, additional, Caia, Andrea, additional, Cook, Mark, additional, Mckiver, Mihaela Popa, additional, Jagannath, Sundar, additional, and Ailawadhi, Sikander, additional

Published
2024
Full Text
View/download PDF

4. Evaluation of Outpatient Administration of Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma: Single Center Experience

Author

Waqar, Syed Hamza Bin, primary, Hansen, Doris K, additional, Freeman, Ciara Louise, additional, De Avila, Gabe, additional, Harvey, Kristy, additional, Grajales, Ariel, additional, Blue, Brandon, additional, Liu, Hien, additional, Baz, Rachid, additional, Alsina, Melissa, additional, Shain, Kenneth, additional, Jain, Michael D., additional, Locke, Frederick L., additional, Castaneda, Omar, additional, and Nishihori, Taiga, additional

Published
2024
Full Text
View/download PDF

5. Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Author

Kumar, Shaji K., primary, Callander, Natalie S., additional, Adekola, Kehinde, additional, Anderson, Larry D., additional, Baljevic, Muhamed, additional, Baz, Rachid, additional, Campagnaro, Erica, additional, Castillo, Jorge J., additional, Costello, Caitlin, additional, D’Angelo, Christopher, additional, Derman, Benjamin, additional, Devarakonda, Srinivas, additional, Elsedawy, Noura, additional, Garfall, Alfred, additional, Godby, Kelly, additional, Hillengass, Jens, additional, Holmberg, Leona, additional, Htut, Myo, additional, Huff, Carol Ann, additional, Hultcrantz, Malin, additional, Kang, Yubin, additional, Larson, Sarah, additional, Lee, Hans, additional, Liedtke, Michaela, additional, Martin, Thomas, additional, Omel, James, additional, Robinson, Timothy, additional, Rosenberg, Aaron, additional, Sborov, Douglas, additional, Schroeder, Mark A., additional, Sherbenou, Daniel, additional, Suvannasankha, Attaya, additional, Valent, Jason, additional, Varshavsky-Yanovsky, Asya Nina, additional, Snedeker, Jenna, additional, and Kumar, Rashmi, additional

Published
2024
Full Text
View/download PDF

6. Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Author

Kumar, Shaji K., primary, Callander, Natalie S., additional, Adekola, Kehinde, additional, Anderson, Larry D., additional, Baljevic, Muhamed, additional, Baz, Rachid, additional, Campagnaro, Erica, additional, Castillo, Jorge J., additional, Costello, Caitlin, additional, D’Angelo, Christopher, additional, Devarakonda, Srinivas, additional, Elsedawy, Noura, additional, Garfall, Alfred, additional, Godby, Kelly, additional, Hillengass, Jens, additional, Holmberg, Leona, additional, Htut, Myo, additional, Huff, Carol Ann, additional, Hultcrantz, Malin, additional, Kang, Yubin, additional, Larson, Sarah, additional, Lee, Hans C., additional, Liedtke, Michaela, additional, Martin, Thomas, additional, Omel, James, additional, Robinson, Timothy, additional, Rosenberg, Aaron, additional, Sborov, Douglas, additional, Schroeder, Mark A., additional, Sherbenou, Daniel, additional, Suvannasankha, Attaya, additional, Valent, Jason, additional, Varshavsky-Yanovsky, Asya Nina, additional, Kumar, Rashmi, additional, and Snedeker, Jenna, additional

Published
2023
Full Text
View/download PDF

7. Supplementary Figure S5 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

8. Supplementary Figure S7 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Table S3 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table S2 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure S1 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figure S2 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figure S3 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure S1 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure S7 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure S2 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure S3 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Table S2 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figure S5 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure S6 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure S6 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

22. Data from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table S4 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Table S4 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table S1 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure S4 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Table S3 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Table S1 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

29. Data from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure S4 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma

Author

Freeman, Ciara L., primary, Atkins, Reginald, primary, Varadarajan, Indumathy, primary, Menges, Meghan, primary, Edelman, Jeffrey, primary, Baz, Rachid, primary, Brayer, Jason, primary, Castaneda Puglianini, Omar, primary, Ochoa-Bayona, Jose Leonel, primary, Nishihori, Taiga, primary, Shain, Kenneth H., primary, Shah, Bijal, primary, Chen, Dung Tsa, primary, Kelley, Linda, primary, Coppola, Domenico, primary, Alsina, Melissa, primary, Antonia, Scott, primary, Anasetti, Claudio, primary, and Locke, Frederick L., primary

Published
2023
Full Text
View/download PDF

33. Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel

Author

Oswald, Laura B., primary, Gudenkauf, Lisa M., additional, Li, Xiaoyin, additional, De Avila, Gabriel, additional, Peres, Lauren C., additional, Kirtane, Kedar, additional, Gonzalez, Brian D., additional, Hoogland, Aasha I., additional, Nguyen, Oanh, additional, Rodriguez, Yvelise, additional, Baz, Rachid C., additional, Shain, Kenneth H., additional, Alsina, Melissa, additional, Locke, Frederick L., additional, Freeman, Ciara, additional, Castaneda Puglianini, Omar, additional, Nishihori, Taiga, additional, Liu, Hien, additional, Blue, Brandon, additional, Grajales-Cruz, Ariel, additional, Jim, Heather S. L., additional, and Hansen, Doris K., additional

Published
2023
Full Text
View/download PDF

34. P-032 Ide-cel versus standard regimens in patients with triple-class–exposed (TCE) relapsed and refractory multiple myeloma (RRMM): a KarMMa-3 analysis in the modified intention to-treat (mITT) population

Author

Manier, Salomon, primary, Ailawadhi, Sikander, additional, Rodriguez-Otero, Paula, additional, Arnulf, Bertrand, additional, Patel, Krina, additional, Solomon, Scott, additional, Baz, Rachid, additional, Jagannath, Sundar, additional, Raje, Noopur, additional, Scheid, Christoph, additional, Mateos, Maria-Victoria, additional, Abdallah, Al-Ola, additional, Einsele, Hermann, additional, Giralt, Sergio, additional, Pabst, Thomas Mueller, additional, Perrot, Aurore, additional, Lin, Yi, additional, Truppel-Hartmann, Anna, additional, Bhatnagar, Rashmi, additional, Felten, Jasper, additional, Caia, Andrea, additional, Piasecki, Julia, additional, Cook, Mark, additional, and Moreau, Philippe, additional

Published
2023
Full Text
View/download PDF

35. MM-059 Incidence and Risk Factors Associated With Bleeding Following Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)

Author

Mohammed, Turab, primary, Peres, Lauren, additional, Colinleitzinger, Christelle, additional, Puglianini, Omar Castaneda, additional, Oswald, Laura, additional, de Avila, Gabe, additional, Grajales-Cruz, Ariel, additional, Blue, Brandon, additional, Ochoa-Bayona, Jose, additional, Khimani, Farhad, additional, Faramand, Rawan, additional, Elmariah, Hany, additional, Lazaryan, Aleksandr, additional, Jain, Michael, additional, Liu, Hein, additional, Nishihori, Taiga, additional, Shain, Ken, additional, Baz, Rachid, additional, Alsina, Melissa, additional, Locke, Frederick, additional, Freeman, Ciara, additional, and Hansen, Doris, additional

Published
2023
Full Text
View/download PDF

36. P-040 Idecabtagene vicleucel (ide-cel) versus standard regimens in patients with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): a KarMMa-3 high-risk subgroup analysis

Author

Patel, Krina, primary, Rodriguez-Otero, Paula, additional, Manier, Salomon, additional, Baz, Rachid, additional, Raab, Marc, additional, Cavo, Michele, additional, Callander, Natalie, additional, Costa, Luciano, additional, Moreau, Philippe, additional, Solomon, Scott, additional, Chen, Christine, additional, Raje, Noopur, additional, Scheid, Christoph, additional, Delforge, Michel, additional, Larsen, Jeremy, additional, Pabst, Thomas Mueller, additional, Suzuki, Kenshi, additional, Truppel-Hartmann, Anna, additional, Yang, Zhihong, additional, Piasecki, Julia, additional, Felten, Jasper, additional, Caia, Andrea, additional, Cook, Mark, additional, Giralt, Sergio, additional, and Mateos, Maria-Victoria, additional

Published
2023
Full Text
View/download PDF

37. POSTER: MM-388 Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens in Patients With Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): A KarMMa-3 Analysis in High-Risk Subgroups

Author

Patel, Krina, primary, Rodríguez-Otero, Paula, additional, Manier, Salomon, additional, Baz, Rachid, additional, Raab, Mark-Steffen, additional, Cavo, Michele, additional, Callander, Natalie, additional, Costa, Luciano J., additional, Moreau, Phillippe, additional, Solomon, Scott, additional, Chen, Christine, additional, Raje, Noopur, additional, Scheid, Christoph, additional, Delforge, Michel, additional, Larsen, Jeremy, additional, Pabst, Thomas, additional, Suzuki, Kenshi, additional, Truppel-Hartmann, Anna, additional, Yang, Zhihong, additional, Piasecki, Julia, additional, Felten, Jasper, additional, Caia, Andrea, additional, Cook, Mark, additional, Giralt, Sergio, additional, and Mateos, Maria-Victoria, additional

Published
2023
Full Text
View/download PDF

38. P-277 Venetoclax versus bortezomib, in combination with daratumumab and dexamethasone, in patients with t(11;14)-positive relapsed or refractory multiple myeloma

Author

Kaufman, Jonathan, primary, Quach, Hang, additional, Baz, Rachid, additional, Vangsted, Annette Juul, additional, Ho, Shir-Jing, additional, Abildgaard, Niels, additional, Laubach, Jacob, additional, Ribrag, Vincent, additional, Gibbs, Simon, additional, Medvedova, Eva, additional, Voorhees, Peter, additional, Jalaluddin, Muhammad, additional, Zeng, Jiewei, additional, Ross, Jeremy, additional, Wang, Xifeng, additional, Fleming, Leanne Lash, additional, Bueno, Orlando, additional, Luo, Yan, additional, and Bahlis, Nizar, additional

Published
2023
Full Text
View/download PDF

39. P-031 Idecabtagene vicleucel (ide-cel) vs standard regimens in patients with triple-class–exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3 subgroup analysis by prior lines of therapy

Author

Manier, Salomon, primary, Rodriguez-Otero, Paula, additional, Mateos, Maria-Victoria, additional, Einsele, Hermann, additional, Bahlis, Nizar, additional, Munshi, Nikhil, additional, Ailawadhi, Sikander, additional, Arnulf, Bertrand, additional, Nooka, Ajay, additional, Vij, Ravi, additional, Abrahamsen, Ingerid Weum, additional, Broijl, Annemiek, additional, Jagannath, Sundar, additional, Benjamin, Reuben, additional, Gergis, Usama, additional, Sborov, Douglas, additional, Iida, Shinsuke, additional, Truppel-Hartmann, Anna, additional, Yang, Zhihong, additional, Bhatnagar, Rashmi, additional, Piasecki, Julia, additional, Felten, Jasper, additional, Caia, Andrea, additional, Cook, Mark, additional, and Baz, Rachid, additional

Published
2023
Full Text
View/download PDF

40. P-213 COVALENT-101: phase I study of BMF-219, a covalent menin inhibitor, in adult patients with AML, ALL (with KMT2A/ MLL1r, NPM1 mutations), DLBCL, MM, and CLL/SLL (NCT05153330)

Author

Rosenberg, Aaron, primary, Baljevic, Muhamed, additional, Amor, Adrian Alegre, additional, Barrientos, Jacqueline, additional, Bashey, Asad, additional, Baz, Rachid, additional, Burgues, Juan Bergua, additional, Delimpasi, Sosana, additional, Kastritis, Efstathios, additional, Latif, Tahir, additional, Lee, Lisa, additional, Mateos, Maria-Victoria, additional, Morillo, Daniel, additional, Montesinos, Pau, additional, Parrondo, Ricardo, additional, Schiller, Gary, additional, Curran, Emily, additional, Kishtagari, Ashwin, additional, Butler, Thomas, additional, Cacovean, Alex, additional, Follit, Courtney, additional, Mandap, Clarissa, additional, Morris, Steve, additional, and Khouri, Jack, additional

Published
2023
Full Text
View/download PDF

41. P-247 Efficacy and safety of linvoseltamab 200 mg in patients with relapsed/refractory multiple myeloma (RRMM): analysis of the LINKER-MM1 study

Author

Dhodapkar, Madhav, primary, Bumma, Naresh, additional, Richter, Joshua, additional, Lee, Hans, additional, Hoffman, James, additional, Suvannasankha, Attaya, additional, Lentzsch, Suzanne, additional, Shah, Mansi, additional, Zonder, Jeffrey, additional, Baz, Rachid, additional, Wu, Ka Lung, additional, Pianko, Matthew, additional, Silbermann, Rebecca, additional, Min, Chang-Ki, additional, Vekemans, Marie-Christiane Madeleine, additional, Munder, Markus, additional, Byun, Ja Min, additional, Lopez, Joaquín Martínez, additional, DeVeaux, Michelle, additional, Lorenc, Karen Rodriguez, additional, Kroog, Glenn, additional, Houvras, Yariv, additional, and Jagannath, Sundar, additional

Published
2023
Full Text
View/download PDF

42. MM-388 Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens in Patients With Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): A KarMMa-3 Analysis in High-Risk Subgroups

Author

Patel, Krina, primary, Rodríguez-Otero, Paula, additional, Manier, Salomon, additional, Baz, Rachid, additional, Raab, Mark-Steffen, additional, Cavo, Michele, additional, Callander, Natalie, additional, Costa, Luciano J., additional, Moreau, Phillippe, additional, Solomon, Scott, additional, Chen, Christine, additional, Raje, Noopur, additional, Scheid, Christoph, additional, Delforge, Michel, additional, Larsen, Jeremy, additional, Pabst, Thomas, additional, Suzuki, Kenshi, additional, Truppel-Hartmann, Anna, additional, Yang, Zhihong, additional, Piasecki, Julia, additional, Felten, Jasper, additional, Caia, Andrea, additional, Cook, Mark, additional, Giralt, Sergio, additional, and Mateos, Maria-Victoria, additional

Published
2023
Full Text
View/download PDF

43. Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysis

Author

Akhtar, Othman Salim, primary, Sheeba, Ba Aqeel, additional, Azad, Farhan, additional, Alessi, Lauren, additional, Hansen, Doris, additional, Alsina, Melissa, additional, Baz, Rachid, additional, Shain, Kenneth, additional, Grajales Cruz, Ariel, additional, Castaneda Puglianini, Omar, additional, Liu, Hien, additional, Blue, Brandon, additional, Nishihori, Taiga, additional, Al Jumayli, Mohammed, additional, Extermann, Martine, additional, Locke, Frederick L., additional, Mhaskar, Rahul, additional, and Freeman, Ciara Louise, additional

Published
2023
Full Text
View/download PDF

44. POSTER: MM-059 Incidence and Risk Factors Associated With Bleeding Following Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)

Author

Mohammed, Turab, primary, Peres, Lauren, additional, Colinleitzinger, Christelle, additional, Puglianini, Omar Castaneda, additional, Oswald, Laura, additional, de Avila, Gabe, additional, Grajales-Cruz, Ariel, additional, Blue, Brandon, additional, Ochoa-Bayona, Jose, additional, Khimani, Farhad, additional, Faramand, Rawan, additional, Elmariah, Hany, additional, Lazaryan, Aleksandr, additional, Jain, Michael, additional, Liu, Hein, additional, Nishihori, Taiga, additional, Shain, Ken, additional, Baz, Rachid, additional, Alsina, Melissa, additional, Locke, Frederick, additional, Freeman, Ciara, additional, and Hansen, Doris, additional

Published
2023
Full Text
View/download PDF

45. Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma

Author

Lee, Dae Hyun, primary, Kumar, Abhishek, additional, Mohammed, Turab, additional, Peres, Lauren C., additional, Alsina, Melissa, additional, Bachmeier, Christina, additional, Blue, Brandon J., additional, Brayer, Jason, additional, Chandrasekhar, Sanjay, additional, Grajales Cruz, Ariel, additional, De Avila, Gabe, additional, Elmariah, Hany, additional, Faramand, Rawan, additional, Freeman, Ciara, additional, Jain, Michael, additional, Khadka, Sushmita, additional, Khimani, Farhad, additional, Liu, Hien, additional, Nishihori, Taiga, additional, Oswald, Laura B., additional, Castaneda Puglianini, Omar A., additional, Shain, Kenneth H., additional, Smith, Eric, additional, Baz, Rachid C., additional, Locke, Frederick L., additional, Oliveira, Guilherme H., additional, Alomar, Mohammed, additional, and Hansen, Doris K., additional

Published
2023
Full Text
View/download PDF

46. P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): KARMMA-3 SUBGROUP ANALYSIS BY PRIOR LINES OF THERAPY

Author

Manier, Salomon, primary, Rodríguez-Otero, Paula, additional, Mateos, Maria-Victoria, additional, Einsele, Hermann, additional, Bahlis, Nizar J, additional, Munshi, Nikhil, additional, Ailawadhi, Sikander, additional, Arnulf, Bertrand, additional, Nooka, Ajay, additional, Vij, Ravi, additional, Weum Abrahamsen, Ingerid, additional, Broijl, Annemiek, additional, Jagannath, Sundar, additional, Benjamin, Reuben, additional, Gergis, Usama, additional, Sborov, Douglas W., additional, Iida, Shinsuke, additional, Truppel-Hartmann, Anna, additional, Yang, Zhihong, additional, Piasecki, Julia, additional, Felten, Jasper, additional, Caia, Andrea, additional, Cook, Mark, additional, and Baz, Rachid, additional

Published
2023
Full Text
View/download PDF

48. S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH-RISK SUBGROUPS

Author

Patel, Krina, primary, Rodríguez-Otero, Paula, additional, Manier, Salomon, additional, Baz, Rachid, additional, Raab, Marc S., additional, Cavo, Michele, additional, Callander, Natalie, additional, Costa, Luciano, additional, Moreau, Philippe, additional, Solomon, Scott, additional, Chen, Christine, additional, Raje, Noopur, additional, Scheid, Christof, additional, Delforge, Michel, additional, Larsen, Jeremy, additional, Pabst, Thomas, additional, Suzuki, Kenshi, additional, Truppel-Hartmann, Anna, additional, Yang, Zhihong, additional, Piasecki, Julia, additional, Felten, Jasper, additional, Caia, Andrea, additional, Cook, Mark, additional, Giralt, Sergio, additional, and Mateos, Maria-Victoria, additional

Published
2023
Full Text
View/download PDF

49. PB2092: INCIDENCE AND RISK FACTORS ASSOCIATED WITH BLEEDING FOLLOWING ANTI-B CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Author

Mohammed, Turab, primary, Shahzad, Moazzam, additional, Peres, Lauren, additional, Khadka, Sushmita, additional, Colinleitzinger, Christelle, additional, Babu, Abida, additional, Doyle, William, additional, Puglianini, Omar Castaneda, additional, Oswald, Laura, additional, De Avila, Gabe, additional, Grajales-Cruz, Ariel, additional, Blue, Brandon, additional, Ochoa-Bayona, Jose, additional, Smith, Eric, additional, Corallo, Salvatore, additional, Khimani4, Farhad, additional, Faramand, Rawan, additional, Elmariah, Hany, additional, Lazaryan, Aleksandr, additional, Jain, Michael, additional, Liu, Hien, additional, Nishihori, Taiga, additional, Shain, Ken, additional, Baz, Rachid, additional, Alsina, Melissa, additional, Locke, Frederick, additional, Freeman, Ciara, additional, and Hansen, Doris, additional

Published
2023
Full Text
View/download PDF

50. Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma

Author

Tantawy, Marwa, primary, Yang, Guang, additional, Algubelli, Raghunandan Reddy, additional, DeAvila, Gabriel, additional, Rubinstein, Samuel M., additional, Cornell, Robert F., additional, Fradley, Michael G., additional, Siegel, Erin M., additional, Hampton, Oliver A., additional, Silva, Ariosto S., additional, Lenihan, Daniel, additional, Shain, Kenneth H., additional, Baz, Rachid C., additional, and Gong, Yan, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results